SEC61G and central nervous system cancer: Liu et al. observed a significant correlation of SEC61G overexpression with poor prognosis based on statistical analysis of data from the Cancer Genome Atlas cohort and the Chinese Glioma Genome Atlas cohort in patients with glioblastoma multiforme (Liu et al., 2019).